Drug class
Botulinum neurotoxin type A; long-acting neuromuscular blocking biologic
Mechanism of action
Enters cholinergic nerve terminals and cleaves SNAP-25, a presynaptic SNARE protein required for acetylcholine-vesicle fusion, thereby inhibiting acetylcholine release and producing temporary chemodenervation of the injected muscle.
General use cases
- Temporary improvement in moderate-to-severe glabellar lines in adults
- Treatment of cervical dystonia in adults; product-specific potency units are not interchangeable with other botulinum toxin products
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
